Sponsor: 
Merck Sharp & Dohme (Australia)
Administration route: 
Subcutaneous injection
Vaccine group: 
Zoster vaccines

Registered for use in people aged ≥50 years.

Live herpes zoster vaccine

Lyophilised powder in a monodose vial with separate diluent.

Each 0.65 mL reconstituted dose contains:

  • ≥19,400 plaque-forming units of live attenuated varicella-zoster virus (Oka/Merck strain)
  • 41.05 mg sucrose
  • 20.53 mg hydrolysed porcine gelatin
  • 8.55 mg urea
  • 0.82 mg monosodium glutamate
  • residual components of MRC-5 cells

Also contains traces of:

  • neomycin
  • bovine serum albumin

For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018